Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.10 CAD
Change Today -0.005 / -4.76%
Volume 150.0K
MDX On Other Exchanges
As of 2:24 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

medx health corp (MDX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/15 - C$0.11
52 Week Low
05/20/15 - C$0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDX HEALTH CORP (MDX)

Related News

No related news articles were found.

medx health corp (MDX) Related Businessweek News

No Related Businessweek News Found

medx health corp (MDX) Details

MedX Health Corp. develops, manufactures, and distributes phototherapy devices. Its products comprise MedX phototherapy devices, MedX rehab console systems, MedX rehab handheld lasers, MedX SLD clusters, MedX rehab portable lasers, MedX dental console systems, MedX Oralase (dental) portable lasers, MedXHOME systems, MedX acupuncture console laser systems, and MedX acupuncture portable lasers. The company also provides MoleMate, a non-invasive melanoma screening device early detection of skin cancer. Its products are used by practitioners in clinics, academic facilities, and hospitals as well as by professional athletes and sports teams for the treatment of arthritis, strains, sprains, carpal tunnel syndrome, dental pain, and tissue repair. The company sells its products to medical equipment dealers primarily in Canada, the United States, Europe, and Asia. MedX Health Corp. was incorporated in 1999 and is headquartered in Mississauga, Canada.

Founded in 1999

medx health corp (MDX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$30.0K
Chief Financial Officer
Total Annual Compensation: C$7.5K
Chief Operating Officer
Total Annual Compensation: C$147.8K
Compensation as of Fiscal Year 2013.

medx health corp (MDX) Key Developments

MedX Health Corp. Completes $500,000 Debt Financing

MedX Health Corp. has completed a $500,000 term loan with a party related to a Director of the Company. The loan is for three years, with an 8% interest rate paid quarterly, and no principal payments to maturity. The Company has the option to repay the loan at any time without penalty. The lender has the option of requiring the principal portion to be repaid in monthly installments to maturity, if certain financial targets are not being met. The debt will be secured by a general security agreement.

MedX Health Corp. Announces Pharmacy Pilot in the United Kingdom

MedX Health Corp. gave an update on recent business developments, announcing that its European pharmacy-focused channel partner commenced a mole-scanning pilot, using MedX's SIAscopy technology, in 25 Alphega Pharmacies in the United Kingdom. The mole-scanning service is based on the successful model in place in 100 Norwegian Boots pharmacies, as well as in a Swedish pharmacy chain where the mole-scanning service has recently grown to 32 locations. To date, this mole-scanning service has identified more than 120 life-threatening melanomas. Alphega Pharmacy is a leading network of independent pharmacists in Europe supporting more than 600 pharmacies in the UK, and 6,500 locations across eight European countries. Alphega is part of the Walgreens-Boots-Alliance.

Medx Health Corp Announces Earnings Results for the First Quarter Ended March 31, 2015

MedX Health Corp. reported earnings results for the first quarter ended March 31, 2015. For the quarter, revenue was $298,619 for the first quarter of 2015, 89% higher than revenue of $157,772 in the 2014 period. The loss was $56,032 or $0.00 per share compared with a loss of $268,732 or $0.00 per share for the three months ended March 31, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDX:CN C$0.10 CAD -0.005

MDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.65 USD 0.00
Cascade Technologies Corp $0.0075 USD -0.002
Verisante Technology Inc C$0.11 CAD +0.005
View Industry Companies

Industry Analysis


Industry Average

Valuation MDX Industry Range
Price/Earnings 100.0x
Price/Sales 6.7x
Price/Book NM Not Meaningful
Price/Cash Flow 138.5x
TEV/Sales 6.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDX HEALTH CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at